On Aug 25, 2021 Calibrate closed a Series B round and raised $100,000,000 from Forerunner Ventures, Founders Fund, Optum Ventures, Threshold, Tiger Global Management, featuring […]
Series B – Zuoshouyisheng
On Aug 25, 2021 Zuoshouyisheng closed a Series B round and raised CN¥100,000,000 from Haier Capital, Hunan Hi-Tech Venture Capital, Qiming Venture Partners, featuring lead […]
Series A – Elixiron Immunotherapeutics
On Aug 23, 2021 Elixiron Immunotherapeutics closed a Series A round and raised $27,000,000 from China Development Industrial Bank (CDIB), DCI Partners, Fubon Financial Holdings, […]
Series A – Flow Neuroscience
On Aug 23, 2021 Flow Neuroscience closed a Series A round and raised $9,000,000 from Global Brain Corporation, HAX, Khosla Ventures, Kirin Holdings, Schox Patent […]
Series B – Immunitas Therapeutics
On Aug 18, 2021 Immunitas Therapeutics closed a Series B round and raised $58,000,000 from 120 Capital Management, Agent Capital, Alexandria Venture Investments, BrightEdge Fund, […]
Series A – Opya
On Aug 18, 2021 Opya closed a Series A round and raised $15,400,000 from Altitude Ventures, Divergent Investments, Panoramic Ventures, Raven One Ventures, SB Opportunity […]
Series A – EpiEndo Pharmaceuticals
On Aug 18, 2021 EpiEndo Pharmaceuticals closed a Series A round and raised €20,000,000 from ABC Ventures, European Innovation Council, Flerie Invest, Kvika Asset Management, […]
Series B – Ultromics
On Aug 16, 2021 Ultromics closed a Series B round and raised £23,700,000 from Blue Venture Fund, GV, Optum Ventures, Oxford Sciences Innovation, featuring lead […]
Series B – andros
On Aug 13, 2021 andros closed a Series B round and raised $12,500,000 from investors, featuring lead investors . About the company: andros is located […]
Series B – Humanoo
On Aug 13, 2021 Humanoo closed a Series B round and raised $10,000,000 from Creathor Ventures, Helsana, Swisshealth Ventures, Verve Ventures, featuring lead investors Swisshealth […]
